* Through this article, Han*hee and 47 others who simply applied for free
Bottom-level buying of Ildong Pharmaceutical (249420) with a cumulative 147% surge profit! We have definitely secured it for you. Congratulations!
Follow-up to Ildong Pharmaceutical! A soaring stock that will quickly rise from the bottom!! Buy at the low point and hit the jackpot!!
‘o o o’ Omicron oral treatment Phase 2 clinical trial approved! + Global clinical trials conducted simultaneously!
A perfect ‘o o o’ treatment without side effects! Explosive inquiries from global major pharmaceutical companies
Global clinical trial agency One PICK!! Completed development at unprecedented speed! Export imminent upon result announcement!
Achieved performance with last year’s sales exceeding 15 times due to demand triggered simultaneously with the world’s first new drug development dominating the 300 trillion global market!
You must buy immediately to get in. VI will be triggered and entry will be difficult.
World’s first development! Patent already filed! Flood of inquiries from global major companies!
Neutralizing antibodies reduced 25 times! Over 10 billion times, domestic companies accelerating volume securing!!
Foreign and institutional investors are already accumulating nearly half of the circulating volume!
**Actual member reviews**
“I applied for the free trial and followed it steadily for 3 days, and it was really amazing to see limit-up profits every day. When I was doing it alone, the limit-up was so difficult, but tasting it every day made me unable to stop, so I immediately paid the membership fee and am receiving VIP service. Considering the low membership fee, they make me earn more every day, so I am just grateful. It’s already been 5 months since I properly started, and I have saved 62 million KRW. Thank you very much.” (VIP office worker Park O-hyun, 37 years old member)
“This stock” that can definitely generate profits, apply for the free trial now and check it out!
We are waiting for your choice.
[Recent limit-up hits]
*22.04.29 Daemo (317850) 2nd limit-up hit!
*22.04.22 Hanil Feed (005860) 4th limit-up hit!
*22.04.20 Geumgang Steel (053260) limit-up hit!
*22.04.12 Mason Capital (021880) limit-up hit!
*22.04.07 KG Steel (016380) limit-up hit!
*22.04.01 Ssangbangwool (102280) limit-up hit!
*22.03.31 Daehan Cable (001440) limit-up hit!
*22.03.14 Zoom Internet (239340) limit-up hit!
*22.03.07 Hyosung O&B (097870) limit-up hit!
*22.03.02 Korea Wire (025550) limit-up hit!
*22.02.28 Boseong Powertech (006910) limit-up hit!
*22.02.21 Dijens (113810) limit-up hit!
*22.02.09 GSE (041920) limit-up hit!
*22.02.03 Ildong Pharmaceutical (053950) 2nd limit-up hit!
[Today’s stocks of interest]
Ildong Pharmaceutical, Kinemaster, Ecocap, Mediance, KG ETS
※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
